Abstract
Pseudobulbar affect (PBA) may occur in association with a variety of neurological diseases, and so may be encountered in the setting of amyotrophic lateral sclerosis, extrapyramidal and cerebellar disorders, multiple sclerosis, traumatic brain injury, Alzheimer's disease, stroke, and brain tumors. The psychological consequences and the impact on social interactions may be substantial. Although it is most commonly misidentified as a mood disorder, particularly depression or a bipolar disorder, there are characteristic features that can be recognized clinically or assessed by validated scales, resulting in accurate identification of PBA, and thus permitting proper management and treatment. Mechanistically, PBA is a disinhibition syndrome in which pathways involving serotonin and glutamate are disrupted. This knowledge has permitted effective treatment for many years with antidepressants, particularly tricyclic antidepressants and selective serotonin reuptake inhibitors. A recent therapeutic breakthrough occurred with the approval by the Food and Drug Administration of a dextromethorphan/quinidine combination as being safe and effective for treatment of PBA. Side effect profiles and contraindications differ for the various treatme...Continue Reading
Citations
Jan 31, 2016·Pharmacology & Therapeutics·Linda NguyenRae R Matsumoto
Feb 24, 2016·Journal of Pain and Symptom Management·Young D ChangTerrence Gutgsell
Dec 20, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Geying WangLingjing Jin
Mar 21, 2015·Socioaffective Neuroscience & Psychology·Zhendong LiYing Wang
Nov 4, 2015·International Journal of Geriatric Psychiatry·Kevin FoleyCharles Yonan
Dec 28, 2018·Neurology. Clinical Practice·Kathryn C FitzgeraldRuth Ann Marrie
Jun 14, 2019·International Journal of MS Care·Jacqueline A LuhowaySarah A Morrow
Jul 2, 2020·Journal of Psychosocial Nursing and Mental Health Services·Deana Shevit Goldin
Apr 6, 2017·Case Reports in Oncological Medicine·Allison N MartinDavid A Lapides
May 2, 2018·Frontiers in Neurology·Moritz Caspar Franz OberstadtAnja Mehnert
Apr 6, 2019·Frontiers in Neurology·Eoin FineganPeter Bede
Jan 17, 2020·Neuropsychology Review·Amelia J HicksMalcolm Hopwood
Apr 8, 2021·Curēus·Razwana KhanamAdam Brufsky
May 25, 2021·Journal of Neuromuscular Diseases·Yuval Nash, Michal Sitty
Jul 27, 2021·Frontiers in Neurology·Sicong TuMatthew C Kiernan